Cost-effectiveness of perampanel as an adjunctive treatment for uncontrolled focal seizures in pediatric patients: a Chinese perspective

BACKGROUND: The incidence of epilepsy is 41–187 per 100,000 person-year in children. The health care costs for children with uncontrolled epilepsy is a huge burden. Perampanel (PER) was effective, safety and well-tolerated as add-on therapy in pediatric patients aged 4 to <12 years with uncontrol...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yani, Dai, Haibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011307/
https://www.ncbi.nlm.nih.gov/pubmed/35433936
http://dx.doi.org/10.21037/atm-22-994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011307/
https://www.ncbi.nlm.nih.gov/pubmed/35433936
http://dx.doi.org/10.21037/atm-22-994

Ejemplares similares